weight loss drugs

News

More data backs Zepbound over Wegovy for weight loss

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk.

Patients

woman holds her lower abdomen in discomfort

Beyond weight loss: Exploring the impact of weight loss medi...

It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.

Market Access

UK weight loss market: M&A opportunities

Recent advancements in weight-loss interventions are transforming the healthcare landscape and presenting new M&A opportunities

Market Access

Therapeutic or cosmetic? Patent strategies for dual-use inno...

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.

Sales & Marketing

Regulators vs weight loss ads: Time to rethink the rules?

“Medicated weight loss isn’t cheating.” Since I first wrote about the rise of

News

Lilly uses Oscars ad to warn about 'untested' GLP-1s

Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector.